Diane Descamps Selected Research

Diane Descamps Research Topics

Disease

32	Infections 04/2024 - 10/2002
17	COVID-19 11/2023 - 01/2020
7	HIV Infections (HIV Infection) 01/2019 - 02/2002
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 06/2002
3	Disease Progression 01/2021 - 11/2012
3	Inflammation (Inflammations) 01/2020 - 11/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Viremia 01/2015 - 05/2005
1	Superinfection 05/2024
1	Obesity 08/2023
1	Respiratory Insufficiency (Respiratory Failure) 08/2023
1	Critical Illness (Critically Ill) 08/2023
1	Respiratory Syncytial Virus Infections 01/2023
1	Coinfection 01/2023
1	Severe Acute Respiratory Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Ageusia (Hypogeusia) 10/2021
1	Anosmia 10/2021
1	Hepatitis B 01/2021
1	Clinical Deterioration 01/2020
1	Multiple Organ Failure (MODS) 01/2020
1	Papillomavirus Infections 05/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Histoplasmosis 01/2018
1	Hepatitis 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Liver Diseases (Liver Disease) 01/2016
1	Chronic Renal Insufficiency 01/2016
1	Chronic Hepatitis C 01/2016

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2002
6	VaccinesIBA 11/2023 - 01/2022
4	AntigensIBA 11/2023 - 07/2020
4	AntibodiesIBA 04/2023 - 01/2020
4	Ritonavir (Norvir)FDA Link 01/2020 - 02/2002
4	Rilpivirine (TMC-278)IBA 01/2019 - 01/2015
3	CytokinesIBA 01/2021 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2012
3	Viral RNAIBA 01/2020 - 10/2002
3	Raltegravir Potassium FDA Link 01/2020 - 01/2011
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 02/2002
2	Foscarnet FDA LinkGeneric 04/2024 - 07/2016
2	EnzymesIBA 01/2023 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2016
2	BNT162 VaccineIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 10/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2009
2	Immunoglobulin M (IgM)IBA 11/2020 - 11/2020
2	Immunoglobulin G (IgG)IBA 11/2020 - 11/2020
2	Lopinavir FDA Link 01/2020 - 06/2009
2	Lipopolysaccharide ReceptorsIBA 01/2013 - 11/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2024
1	ibalizumabIBA 04/2024
1	Staphylococcal Protein A (Protein A)IBA 11/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 08/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	Interferon-alpha (Interferon Alfa)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 10/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Abatacept (Orencia)FDA Link 01/2021
1	bamlanivimabIBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	GS-441524IBA 10/2020
1	remdesivirIBA 10/2020
1	GlucocorticoidsIBA 01/2020
1	etravirine (TMC-125)FDA Link 01/2020
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Methylprednisolone FDA LinkGeneric 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	SolutionsIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Human immunodeficiency virus 2 p16 proteaseIBA 10/2019
1	tofacitinibIBA 05/2019
1	IntegrasesIBA 01/2019
1	SiliconesIBA 01/2019
1	Tenofovir (Viread)FDA Link 01/2018
1	Emtricitabine (Emtriva)FDA Link 01/2018
1	Itraconazole (Sporanox)FDA LinkGeneric 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2017
1	Cyclophilins (Cyclophilin)IBA 01/2017
1	Zidovudine (Retrovir)FDA LinkGeneric 07/2016
1	SofosbuvirIBA 01/2016

Therapy/Procedure

11	Therapeutics 11/2023 - 02/2002
3	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 01/2007
2	Salvage Therapy 04/2024 - 07/2016
2	Renal Dialysis (Hemodialysis) 10/2020 - 01/2016
2	Art Therapy 01/2018 - 01/2016
1	Critical Care (Surgical Intensive Care) 10/2022
1	Patient Isolation 01/2021
1	Condoms (Condom) 01/2021
1	Personal Protective Equipment 01/2021
1	Oral Administration 01/2020